Alzheimer’s Placebo May Become Disease-Modifying Drug For Affiris
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotech shifts development plans after Phase II study shows surprising, but promising, results – albeit in the wrong arm of the study.